Quinoline, 8-[(4S)-4,5-dihydro-4-(phenylmethyl)-2-oxazolyl]-

Quinoline, 8-[(4S)-4,5-dihydro-4-(phenylmethyl)-2-oxazolyl]- Suppliers list
Company Name: Shanghai Anyinuo Biomedical Technology Co., Ltd.  
Tel: 021-34625901
Email: 420970979@qq.com
Company Name: Yangzhou modier Electronic Materials Co., Ltd  
Tel: 13761402923 19975033992
Email: market@modeltemol.com
Company Name: Hubei yongkuo Technology Co., Ltd  
Tel: 027-59223108 15972152991
Email: 1248580099@qq.com
Company Name: Hubei xingongli Chemical Co., Ltd  
Tel: 027-027-59106151 15172325309
Email: 1400858877@qq.com
Company Name: Hangzhou Nanyuan Organic Silicone Technology Co. Ltd  
Tel: 15868422438
Email: sales@nanyuan-chem.com
Quinoline, 8-[(4S)-4,5-dihydro-4-(phenylmethyl)-2-oxazolyl]- Basic information
Product Name:Quinoline, 8-[(4S)-4,5-dihydro-4-(phenylmethyl)-2-oxazolyl]-
Synonyms:Quinoline, 8-[(4S)-4,5-dihydro-4-(phenylmethyl)-2-oxazolyl]-;(S)-4-benzyl-2-(quinolin-8-yl)-4,5-dihydrooxazole
CAS:220628-97-7
MF:C19H16N2O
MW:288.34
EINECS:
Product Categories:
Mol File:220628-97-7.mol
Quinoline, 8-[(4S)-4,5-dihydro-4-(phenylmethyl)-2-oxazolyl]- Structure
Quinoline, 8-[(4S)-4,5-dihydro-4-(phenylmethyl)-2-oxazolyl]- Chemical Properties
Boiling point 479.5±18.0 °C(Predicted)
density 1.19±0.1 g/cm3(Predicted)
storage temp. 2-8°C, protect from light, stored under nitrogen
pka3.99±0.17(Predicted)
AppearanceWhite to off-white Powder
Optical Rotation29.26°(C=1.00 CHCL3)
Safety Information
MSDS Information
Quinoline, 8-[(4S)-4,5-dihydro-4-(phenylmethyl)-2-oxazolyl]- Usage And Synthesis
Quinoline, 8-[(4S)-4,5-dihydro-4-(phenylmethyl)-2-oxazolyl]- Preparation Products And Raw materials
Tag:Quinoline, 8-[(4S)-4,5-dihydro-4-(phenylmethyl)-2-oxazolyl]-(220628-97-7) Related Product Information
(S)-4-Phenyl-2-(quinolin-8-yl)-4,5-dihydrooxazole Quinoline, 8-[(4R)-4,5-dihydro-4-phenyl-2-oxazolyl]- Quinoline, 8-[(4R)-4,5-dihydro-4-(phenylmethyl)-2-oxazolyl]- Quinoline, 8-(4,5-dihydro-4-phenyl-2-oxazolyl)- Quinoline, 8-[(4R)-4,5-dihydro-4-(1-methylethyl)-2-oxazolyl]- Quinoline, 8-[(4S)-4,5-dihydro-4-(1-methylethyl)-2-oxazolyl]-